Form 8-K - Current report:
SEC Accession No. 0001493152-21-008244
Filing Date
2021-04-08
Accepted
2021-04-07 20:20:15
Documents
30
Period of Report
2021-04-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32392
2 ex99-1.htm EX-99.1 27387
3 ex99-1_001.jpg GRAPHIC 86099
4 ex99-1_002.jpg GRAPHIC 221522
5 ex99-1_003.jpg GRAPHIC 108457
6 ex99-1_004.jpg GRAPHIC 149192
7 ex99-1_005.jpg GRAPHIC 120196
8 ex99-1_006.jpg GRAPHIC 119358
9 ex99-1_007.jpg GRAPHIC 172972
10 ex99-1_008.jpg GRAPHIC 154451
11 ex99-1_009.jpg GRAPHIC 147841
12 ex99-1_010.jpg GRAPHIC 168941
13 ex99-1_011.jpg GRAPHIC 147966
14 ex99-1_012.jpg GRAPHIC 118991
15 ex99-1_013.jpg GRAPHIC 186487
16 ex99-1_014.jpg GRAPHIC 92608
17 ex99-1_015.jpg GRAPHIC 108348
18 ex99-1_016.jpg GRAPHIC 114987
19 ex99-1_017.jpg GRAPHIC 207719
20 ex99-1_018.jpg GRAPHIC 189479
21 ex99-1_019.jpg GRAPHIC 90522
22 ex99-1_020.jpg GRAPHIC 102738
23 ex99-1_021.jpg GRAPHIC 147277
24 ex99-1_022.jpg GRAPHIC 49066
25 ex99-1_023.jpg GRAPHIC 49386
26 ex99-1_024.jpg GRAPHIC 151819
27 ex99-1_025.jpg GRAPHIC 127700
28 ex99-1_026.jpg GRAPHIC 168108
29 ex99-1_027.jpg GRAPHIC 130050
30 ex99-1_028.jpg GRAPHIC 123221
  Complete submission text file 0001493152-21-008244.txt   5235675
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 21813524
SIC: 7389 Services-Business Services, NEC